Enhanced Blood Lymphocytes Apoptosis in Children with Inflammatory Bowel Disease

Table 1

Laboratory parameters in studied groups.

	UC flare; mean (±SD)	UC remission; mean (±SD)	CD flare; mean (±SD)	CD remission; mean (±SD)	Control; mean (±SD)
TLC (10^3/L^−6)	6.7±1.4	6.5±1.5	8.9±1.8^∗	8.2±0.6	7.7±2.3
Lymphocytes%	39.2±11.5	35.9±12.9	38.5±19.1	39.5±16	45.8±15.3
Hemoglobin (gm/dL)	9.6±2.2^∗	11.2±1.2^∗	9.8±1.5^∗	10.5±1.6^∗	12.3±0.7
Platelets (10^3/L^−6)	249±63	257.3±107.6	352.6±175.4^∗	346.5±61.1^∗	280±31
ESR (mm/hr)	33.4±8.9^∗	30.2±11.2^∗	41.1±5.7^∗	34.3±12.3^∗	7.6±3.1
ALT (u/L)	26.8±4.4^∗	27.9±4.0^∗	22.5±7.1^∗	26.5±2.2^∗	17.9±6.2
AST (u/L)	33.9±3.8^∗	33.0±3.6^∗	28.7±8.0^∗	30.1±5.3^∗	17.9±6.9
Creatinine (mg/dL)	0.39±0.1	0.3±0.1	0.27±0.04	0.23±0.04	0.32±0.14

Test of significance used is t-test for independent samples. ^∗𝑃<0.05: significant in the patients groups in relation to controls.
UC: ulcerative colitis; CD: Crohn’s disease.